Kingking(SZ:002094) 证券时报·2025-07-07 11:26Market Overview - The A-share market showed mixed results on July 7, with the Shanghai Composite Index closing at 3473.13 points, up 0.02%, while the Shenzhen Component Index fell by 0.7% to 10435.51 points. The ChiNext Index decreased by 1.21% to 2130.19 points, and the North Star 50 Index dropped by 0.93%. Total trading volume in the A-share market was 12272.11 billion, a decrease of 2274.88 billion from the previous trading day [1]. Capital Flow - The main capital in the A-share market experienced a net outflow of 140.42 billion, with an opening net outflow of 86.67 billion and a closing net outflow of 9.72 billion [2]. - The CSI 300 index saw a net outflow of 43.46 billion, while the ChiNext experienced a net outflow of 92.68 billion. Conversely, the Sci-Tech Innovation Board recorded a net inflow of 3.55 billion [4]. Sector Performance - Among the 12 sectors in the Shenwan first-level industry classification, 12 sectors saw net capital inflows, with the public utilities sector leading with a net inflow of 35.12 billion [6]. - The top five sectors with net capital inflows included: - Public Utilities: 35.12 billion, up 3.21% - Real Estate: 25.82 billion, up 1.86% - Construction Decoration: 12.20 billion, up 1.04% - Electric Equipment: 8.42 billion, up 1.25% - Environmental Protection: 6.68 billion, up 0.86% [7]. Institutional Activity - The institutional buying activity was notable in several stocks, with Qingdao Kingking leading with a net inflow of 6.41 billion [8]. - The top stocks with institutional net buying included: - Qingdao Kingking: 9449.43 million, up 9.99% - Yihua New Materials: 4887.98 million, down 8.59% - Haoshanghao: 3158.16 million, down 5.14% [10]. Institutional Focus - Recent institutional attention was directed towards several stocks, with notable ratings and target prices: - Ruantong Power: Buy rating, target price 66.97, current price 51.90, upside potential 29.04% - Wuxi Zhenhua: Buy rating, target price 37.03, current price 32.75, upside potential 13.07% - Dize Pharmaceutical-U: Buy rating, target price 89.42, current price 64.71, upside potential 38.19% [11].